IPM Take
The tobacco policy battle is no longer only about cigarettes. It is about addiction design. Nicotine pouches, e-cigarettes and heated tobacco products are being sold through flavours, packaging, influencers and lifestyle branding that make cardiovascular risk look harmless, fashionable or even functional. That is the policy failure: regulation is still chasing old product categories while industry is engineering new routes to dependence. For personalised prevention, this matters because cardiovascular risk is not only genetic, metabolic or clinical. It is also manufactured, marketed and politically tolerated.
Executive Summary
On World No Tobacco Day 2026, the World Heart Federation warned that newer tobacco and nicotine products are a growing threat to cardiovascular health. The warning aligns with WHO’s 2026 campaign, “Unmasking the appeal”, which focuses on how tobacco and nicotine industries use product design, flavours, packaging and digital marketing to attract young people.
WHO reports that at least 40 million children aged 13–15 use tobacco products globally, and at least 15 million adolescents in that age group use e-cigarettes. In countries with available data, adolescents are on average nine times more likely to vape than adults. WHO has also warned that around 160 countries still lack specific regulations for nicotine pouches.
The cardiovascular issue is not simply whether these products are less harmful than cigarettes for established smokers. The deeper policy question is whether governments are allowing a new commercial addiction pathway to grow faster than public health regulation can respond.
Why it matters
- Policymakers and public authorities: Need to regulate nicotine products by addiction potential, youth appeal and cardiovascular risk, not just by whether they contain tobacco leaf or combustion.
- Clinicians and providers: Cardiology and primary care pathways should treat nicotine use as a core cardiovascular prevention issue, with cessation support built into routine care.
- Regulators: Need to close loopholes around flavours, digital marketing, synthetic nicotine, nicotine pouches and misleading claims before youth uptake becomes entrenched.
- Industry / innovation partners: The harm-reduction argument cannot become a shield for recruiting new nicotine users. Products marketed as alternatives must be separated from products engineered to expand the nicotine market.
The next cardiovascular policy failure may not look like a cigarette. It may look like a pouch, a vape, a heated tobacco stick, or a flavoured device sold as modern, clean and socially acceptable.
That is the point of the World Heart Federation’s latest warning. Marking World No Tobacco Day 2026, WHF argued that newer tobacco and nicotine products are not a harmless side story in cardiovascular prevention. They are part of a wider commercial strategy to sustain addiction while public policy struggles to keep pace.
This is not a minor public health issue. Tobacco use and exposure to second-hand emissions are responsible for more than 7 million deaths each year. WHF also notes that tobacco accounted for around 15% of cardiovascular-related deaths in 2023. Nicotine itself is not neutral. It can affect heart rate, blood pressure, endothelial function and other pathways directly relevant to cardiovascular disease.
Yet the market has moved faster than the law. E-cigarettes, heated tobacco products and nicotine pouches are promoted through flavours, sleek packaging, lifestyle branding and misleading health claims. The products are not only being sold as alternatives. They are being designed as entry points.
WHO’s 2026 World No Tobacco Day campaign makes the political stakes clear. At least 40 million children aged 13–15 use tobacco products globally, and at least 15 million adolescents use e-cigarettes. In countries with available data, adolescents are on average nine times more likely to vape than adults. That is not accidental. That is market design.
Nicotine pouches expose the regulatory gap even more clearly. WHO has warned that around 160 countries still have no specific regulations for these products, despite rapid sales growth worldwide. This means addiction can be packaged, flavoured, promoted and distributed before many governments have even decided what legal category the product belongs to.
The cardiovascular community should not treat this as someone else’s problem. Prevention cannot be personalised if population-level risk factors are being aggressively manufactured. A health system can invest in lipid testing, hypertension pathways and cardiometabolic prevention, but those gains are weakened if youth nicotine exposure is normalized through products designed to look harmless.
There is also a dangerous policy confusion around cessation. Nicotine replacement therapies and approved cessation medicines have a place in evidence-based treatment. But recreational nicotine products should not be marketed as cessation tools unless they have been formally assessed and approved for that purpose by relevant regulators. Harm reduction for adult smokers must not become an open door to youth addiction.
The policy response is not mysterious. WHF calls for full implementation of the WHO Framework Convention on Tobacco Control, including stronger protection from industry interference and better cessation support. It also calls for bans on flavouring agents in tobacco and recreational nicotine products, restrictions on misleading claims, smoke- and vape-free public places, and stronger research on the long-term cardiovascular effects of newer nicotine products.
The real question is political will.
Governments know how this story ends when regulation comes late. First comes innovation. Then youth uptake. Then normalization. Then disease burden. Then health systems are asked to pay for the consequences.
Cardiovascular prevention should not wait for another generation of nicotine users to become patients. The pouch, the vape and the heated stick are not just consumer products. They are a stress test for whether public health policy can still act before industry writes the next chapter.
